Moderna
MRNA
#1630
Rank
S$13.06 B
Marketcap
$33.79
Share price
-2.41%
Change (1 day)
-75.50%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total debt

Total debt on the balance sheet as of December 2024 : S$1.00 Billion

According to Moderna 's latest financial reports the company's total debt is S$1.00 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Moderna - Total debt on balance sheet (from 2017 to 2024)

Total debt by year

Year Total debt Change
2024-12-31S$1.01 B-38.15%
2023-12-31S$1.64 B2.05%
2022-12-31S$1.60 B29.91%
2021-12-31S$1.23 B294.96%
2020-12-31S$0.31 B75.7%
2019-12-31S$0.17 B290.05%
2018-12-31S$45.75 M118.06%
2017-12-31S$20.98 M15.98%
2016-12-31S$18.09 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
S$0.36 M-99.96%๐Ÿ‡บ๐Ÿ‡ธ USA
S$49.93 B 4,868.01%๐Ÿ‡บ๐Ÿ‡ธ USA
S$24.99 M-97.51%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.74 B 73.50%๐Ÿ‡บ๐Ÿ‡ธ USA
S$42.05 B 4,084.47%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
S$0.70 B-29.68%๐Ÿ‡บ๐Ÿ‡ธ USA
S$49.29 B 4,804.15%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA